Kalle Malmberg

Kalle Malmberg is a Professor at the Department of Medicine, Huddinge, Karolinska Institutet, with dual affiliation to Oslo University Hospital. His research focuses on the molecular mechanisms of Natural Killer (NK) cell differentiation, KIR receptor dynamics, and HLA-E interactions in health and disease.

• Key translational efforts include off-the-shelf NK cell therapy platforms and clinical trials for refractory malignancies
• Funding sources: Cancerfonden, EU Horizon 2020, Vetenskapsrådet

Research Trends: Recent publications highlight genetic engineering of NK cells to overcome immune suppression in cancer, KIR-HLA polymorphism in transplantation outcomes, and single-cell technologies for repertoire analysis.

• Students: Hannah Cuthbertson Husbyn, Herman Krogstad Netskar
• Collaborative Networks: IMTAC, Theme Center for Regenerative Medicine